CU Boulder | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

8,200 results for “CU Boulder”

Trials

View all 7795 →

Not yet recruiting

Safety and Preliminary Diagnostic Performance of [⁶⁴Cu]Cu-RAX301 in Prostate Cancer

52 participants · First posted Aug 14, 2026

A Clinical Study to Evaluate the Safety, Pharmacokinetic Profile and Efficacy of CU-20401

48 participants · First posted Jan 19, 2022

A Phase I Clinical Trial Evaluating the Safety, Tolerability, and Pharmacokinetics of CU-40101 Liniment in Single and Multiple Doses in Adult Male Androgenic Alopecia Subjects

62 participants · First posted May 18, 2022

Drugs

View all 127 →

BR-9001(Boulder BioScience)

CU-06

CU-01

Organizations

View all 17 →

UNIVERSITY OF COLORADO BOULDER

United States

CU CHEMIE UETIKON GmbH

Germany

CU Anschutz Medical Campus

United States

News

View all 261 →

Gecko-Inspired Nanoparticles Show Promise for Targeted Bladder Cancer Therapy

New Miniature Microscope Watches and Controls Individual Brain Cells During Natural Movement

Renovare Therapeutics Emerges from Stealth Mode with $33.5M ARPA-H Funding for Osteoarthritis Regenerative Therapies

Page 1 of 820